Financings in Brief: Rochester Medical
This article was originally published in The Gray Sheet
Executive Summary
Rochester Medical: Registration is filed with the Securities and Exchange Commission for a secondary offering of 1.3 mil. shares of common stock to "selected institutional investors." A portion of the proceeds are tabbed for development and commercialization of the Stewartville, Minnesota firm's antibacterial Foley catheter and FemSoft insert for management of female stress incontinence. The remainder of the funds will be used for scale-up of manufacturing facilities, sales force expansion, R&D and for "working capital and other corporate purposes." Vector Securities International is the placement agent for the securities...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.